Matt Stober serves as an Advisory Partner.
Matt has extensive experience in the biopharma and cell/gene therapy development and manufacturing industries having held senior leadership roles in operations at Novartis, Merck, Pfizer and GlaxoSmithKline. He is currently the CEO of Abzena, a biologics and bioconjugate-focused CDMO that provides outsourced manufacturing support for therapeutic companies from research to commercial production.